Table 5.
Correlation between change in LVESD and other variables using univariable and multivariable linear analysis
| Univariable linear analysis | Multivariable linear analysis | |||||
|---|---|---|---|---|---|---|
| Beta | 95%CI | P value | Beta | 95%CI | P value | |
| Age | − 0.017 | − 0.113 to 0.079 | 0.722 | − 0.007 | − 0.092 to 0.078 | 0.872 |
| Sex (Female) | 1.339 | − 1.779 to 4.457 | 0.397 | − 0.255 | − 2.964 to 2.455 | 0.853 |
| T2DM | − 0.585 | − 2.755 to 1.585 | 0.595 | − 0.988 | − 2.859 to 0.884 | 0.298 |
| HDL− C | 4.661 | 0.946 to 8.376 | 0.014 | 2.633 | − 0.643 to 5.909 | 0.114 |
| WBC | 0.442 | 0.017 to 0.868 | 0.042 | 0.390 | 0.036 to 0.743 | 0.031 |
| SHR | 5.497 | 1.303 to 9.690 | 0.011 | 5.079 | 1.421 to 8.738 | 0.007 |
| Total ischemic time | 0.007 | 0.001 to 0.015 | 0.051 | 0.007 | 0.001 to 0.013 | 0.024 |
| Number of diseased vessels | − 0.941 | − 2.269 to 0.387 | 0.163 | − 0.163 | − 1.286 to 0.959 | 0.774 |
| Baseline LVEF | − 0.016 | − 0.141 to 0.108 | 0.795 | |||
| Baseline LVESD | − 0.570 | − 0.726 to − 0.414 | < 0.0001 | − 0.566 | − 0.713 to − 0.419 | < 0.0001 |
LVESD, left ventricular end-systolic diameter; Changer in LVESD, change in LVESD was defined as (LVESD at 6 months after infarction) minus (baseline LVESD);T2DM, type 2 diabetes mellitus; HDL, high density lipoprotein cholesterol; WBC, white blood cell; SHR, stress hyperglycemia ratio; LVEF, left ventricular ejection fraction; CI, confidence interval